Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment

Lihong Li,Rui Yu,Tiange Cai,Zhen Chen,Meng Lan,Tengteng Zou,Bingyue Wang,Qi Wang,Yiye Zhao,Yu Cai

DOI: https://doi.org/10.1016/j.intimp.2020.106939

IF: 5.714

2020-11-01

International Immunopharmacology

Abstract:<p>Chronic inflammation and immune responses are two core element that characterize the tumor microenvironment. A large number of immune/inflammatory cells (including tumor associated macrophages, neutrophils and myeloid derived suppressor cells) as well as cytokines (such as IL-6, IL-10, TGF-β) are present in the tumor microenvironment, which results in both a chronic inflammatory state and immunosuppression. As a consequence tumor cell migration, invasion, metastasis and anticancer drug sensitivity are modulated. On the one hand, secreted cytokines change the function of cytotoxic T lymphocytes and antigen presenting cells, thereby inhibiting tumor specific immune responses and consequently inducing a special immunosuppressive microenvironment for tumor cells. On the other hand, tumor cells change the differentiation and function of immune/inflammatory cells in the tumor microenvironment especially via the NF-κB and STAT3 signaling pathways. This may promote proliferation of tumor cells. Here we review these double edged effects of immune/inflammatory cells and cytokines on tumor cells, and explored their interactions with inflammation, hypoxia, and immune responses in the tumor microenvironment. The tumor inflammatory or immunosuppressive reactions mediated by the high activity of NF-κB or STAT3 can occur alone or simultaneously, and there is a certain connection between them. Inhibiting the NF-κB or STAT3 signaling pathway is likely to curb the growth of tumor cells, reduce the secretion of pro-inflammatory factors, and enhance the anti-tumor immune response.</p>

pharmacology & pharmacy,immunology

What problem does this paper attempt to address?

The paper primarily explores the dual roles of immune cells (such as tumor-associated macrophages [TAMs] and tumor-associated neutrophils [TANs]) and cytokines (such as IL-6, IL-10, TGF-β) in inflammation and immune suppression within the tumor microenvironment. It also investigates how these factors influence tumor cell proliferation, invasion, metastasis, and sensitivity to chemotherapeutic drugs through the NF-κB and STAT3 signaling pathways.

Specifically, the paper aims to address the following issues:
1. **The role of immune cells and cytokines in the tumor microenvironment**: Investigate how immune cells (such as TAMs and TANs) and the cytokines they secrete create an inflammatory or immunosuppressive environment that favors tumor growth within the tumor microenvironment.
2. **Mechanisms of the NF-κB and STAT3 signaling pathways**: Explore how these two signaling pathways regulate the functions of immune cells and their roles in promoting tumor cell proliferation, invasion, and metastasis.
3. **Mechanisms of immune evasion**: Study how tumor cells evade the immune system's attack by altering the functions of immune cells, thereby promoting tumor development.
4. **Potential therapeutic targets**: Explore the possibility of inhibiting tumor growth, reducing the secretion of pro-inflammatory factors, and enhancing anti-tumor immune responses by inhibiting the NF-κB or STAT3 signaling pathways.